Community Trust & Investment’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,477
Closed -$883K 94
2017
Q3
$883K Sell
11,477
-102
-0.9% -$7.7K 0.09% 62
2017
Q2
$866K Sell
11,579
-187
-2% -$13.3K 0.1% 65
2017
Q1
$783K Buy
11,766
+243
+2% +$16.2K 0.09% 70
2016
Q4
$752K Hold
11,523
0.09% 69
2016
Q3
$815K Sell
11,523
-920
-7% -$67K 0.1% 64
2016
Q2
$920K Sell
12,443
-167,439
-93% -$11.6M 0.12% 60
2016
Q1
$11.7M Buy
179,882
+8,963
+5% +$610K 1.5% 32
2015
Q4
$13.2M Buy
170,919
+908
+0.5% +$72.1K 1.72% 27
2015
Q3
$14M Buy
170,011
+2,093
+1% +$186K 1.89% 17
2015
Q2
$14.8M Sell
167,918
-1,817
-1% -$167K 1.94% 21
2015
Q1
$15M Sell
169,735
-58,409
-26% -$5.18M 2.02% 20
2014
Q4
$18.9M Buy
228,144
+55,183
+32% +$4.57M 2.61% 10
2014
Q3
$14.6M Sell
172,961
-19,907
-10% -$1.61M 2.13% 20
2014
Q2
$15.6M Buy
192,868
+11,572
+6% +$910K 2.37% 20
2014
Q1
$13.8M Buy
181,296
+6,629
+4% +$483K 2.33% 20
2013
Q4
$12.6M Buy
174,667
+1,145
+0.7% +$79.6K 2.31% 18
2013
Q3
$11.9M Buy
173,522
+53
+0% +$3.51K 2.44% 14
2013
Q2
$11M Buy
+173,469
New +$11.3M 2.33% 14

Other funds holding NVS

Community Trust & Investment's NVS Position: Q4 2017 in Review

Community Trust & Investment sold out of Novartis (NVS) in Q4 2017, closing a stake of 11,477 shares — an estimated $883K sold.

Community Trust & Investment first reported a position in NVS in Q2 2013 and held it in 18 quarters. The position peaked at $18.9M in Q4 2014. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • Community Trust & Investment reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
  • Community Trust & Investment sold 11,477 Novartis shares in Q4 2017, an estimated $883K.
  • Community Trust & Investment first reported a position in Novartis in Q2 2013 and held it in 18 quarters.
  • Community Trust & Investment's Novartis position peaked at $18.9M in Q4 2014.
  • 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Community Trust & Investment's 13F filing for Q4 2017, filed 26 Jan 2018.